[An update on the management of Raynaud's phenomenon]
- PMID: 1751694
[An update on the management of Raynaud's phenomenon]
Abstract
Basic knowledge of clinical management of Raynaud's phenomenon was established and reviewed. Body protection against cold weather and the avoiding of all activities which cause the setting off of the ischemic episodic trigger are the first step in the therapy for this type of patient. Medical treatment includes vasoactive drugs and other drugs which act against the different factors such as plasmapheresis, sympathectomy and electric neurostimulation must be reserved for patients with severe vascular symptoms.
Similar articles
-
[Medical treatment of the Raynaud phenomenon].Phlebologie. 1987 Jan-Mar;40(1):47-9. Phlebologie. 1987. PMID: 3033711 French.
-
Treatment of Raynaud's phenomenon.Autoimmun Rev. 2008 Oct;8(1):62-8. doi: 10.1016/j.autrev.2008.07.002. Epub 2008 Aug 8. Autoimmun Rev. 2008. PMID: 18692160 Review.
-
[Raynaud's phenomenon: clinical aspects of the disease].Vestn Khir Im I I Grek. 2001;160(2):118-22. Vestn Khir Im I I Grek. 2001. PMID: 11496483 Review. Russian. No abstract available.
-
Raynaud's phenomenon.J Vasc Nurs. 2001 Sep;19(3):87-92; quiz 93-4. doi: 10.1067/mvn.2001.117786. J Vasc Nurs. 2001. PMID: 11533581 Review.
-
Pharmacotherapy of Raynaud's phenomenon.Drugs. 1996 Nov;52(5):682-95. doi: 10.2165/00003495-199652050-00006. Drugs. 1996. PMID: 9118818 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical